Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

CCR Translations

  • CCR Translations
    Overcoming Cancer Immune Tolerance and Escape
    Guy T. Clifton and George E. Peoples
    Clin Cancer Res February 1 2009 15 (3) 749-751; DOI:10.1158/1078-0432.CCR-08-2805

Molecular Pathways

  • Molecular Pathways
    A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
    Jer-Yen Yang and Mien-Chie Hung
    Clin Cancer Res February 1 2009 15 (3) 752-757; DOI:10.1158/1078-0432.CCR-08-0124

  • Molecular Pathways
    Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and Inflammation
    Eugene W. Gerner and Frank L. Meyskens Jr.
    Clin Cancer Res February 1 2009 15 (3) 758-761; DOI:10.1158/1078-0432.CCR-08-2235

Human Cancer Biology

  • Human Cancer Biology
    An Interstitial Deletion at 3p21.3 Results in the Genetic Fusion of MLH1 and ITGA9 in a Lynch Syndrome Family
    Claus Meyer, Angela Brieger, Guido Plotz, Nicole Weber, Sandra Passmann, Theo Dingermann, Stefan Zeuzem, Joerg Trojan and Rolf Marschalek
    Clin Cancer Res February 1 2009 15 (3) 762-769; DOI:10.1158/1078-0432.CCR-08-1908

  • Human Cancer Biology
    Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
    Taishi Yamashita, Hideto Tamura, Chikako Satoh, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Asaka Kondo, Takashi Tsuji, Kazuo Dan and Kiyoyuki Ogata
    Clin Cancer Res February 1 2009 15 (3) 770-777; DOI:10.1158/1078-0432.CCR-08-0501

  • Human Cancer Biology
    The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
    Andrew H. Beck, Inigo Espinosa, Badreddin Edris, Rui Li, Kelli Montgomery, Shirley Zhu, Sushama Varma, Robert J. Marinelli, Matt van de Rijn and Robert B. West
    Clin Cancer Res February 1 2009 15 (3) 778-787; DOI:10.1158/1078-0432.CCR-08-1283

  • Human Cancer Biology
    Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases
    Roble G. Bedolla, Yu Wang, Alfredo Asuncion, Karim Chamie, Salma Siddiqui, Maria M. Mudryj, Thomas J. Prihoda, Javed Siddiqui, Arul M. Chinnaiyan, Rohit Mehra, Ralph W. de Vere White and Paramita M. Ghosh
    Clin Cancer Res February 1 2009 15 (3) 788-796; DOI:10.1158/1078-0432.CCR-08-1402

  • Human Cancer Biology
    Identification and Characterization of a Novel Melanoma Tumor Suppressor Gene on Human Chromosome 6q21
    Jackie Mei-Wah Fung, Ross Smith, Melissa A. Brown, Sze Hang Lau, Dan Xie, George K. Lau and Xin-Yuan Guan
    Clin Cancer Res February 1 2009 15 (3) 797-803; DOI:10.1158/1078-0432.CCR-08-1472

  • Human Cancer Biology
    Expression of a BTB/POZ Protein, NAC1, Is Essential for the Proliferation of Normal Cyclic Endometrial Glandular Cells and Is Up-regulated by Estrogen
    Masako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, Atsuko Katagiri, Kouji Iida, Naomi Nakayama and Kohji Miyazaki
    Clin Cancer Res February 1 2009 15 (3) 804-811; DOI:10.1158/1078-0432.CCR-08-2134

  • Human Cancer Biology
    Prognostic Implications of and Relationship Between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma
    Hwan Seok Lee, Baek-Hee Kim, Nam-Yun Cho, Eun Joo Yoo, Minhee Choi, So-Hyun Shin, Ja-June Jang, Kyung-Suk Suh, Yong Sung Kim and Gyeong Hoon Kang
    Clin Cancer Res February 1 2009 15 (3) 812-820; DOI:10.1158/1078-0432.CCR-08-0266

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-Small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors
    Suhail Akhtar, Syed M. Meeran, Nandan Katiyar and Santosh K. Katiyar
    Clin Cancer Res February 1 2009 15 (3) 821-831; DOI:10.1158/1078-0432.CCR-08-1901

  • Cancer Therapy: Preclinical
    CAT-8015: A Second-Generation Pseudomonas Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies
    Ralph F. Alderson, Robert J. Kreitman, Tianling Chen, Peter Yeung, Ronald Herbst, Judy A. Fox and Ira Pastan
    Clin Cancer Res February 1 2009 15 (3) 832-839; DOI:10.1158/1078-0432.CCR-08-1456

  • Cancer Therapy: Preclinical
    Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells
    Tai-Lung Cha, Mei-Jen Chuang, Sheng-Tang Wu, Guang-Huan Sun, Sun-Yran Chang, Dah-Shyong Yu, Shih-Ming Huang, Steven Kuan-Hua Huan, Tse-Chou Cheng, Tzu-Ting Chen, Pao-Luo Fan and Pei-Wen Hsiao
    Clin Cancer Res February 1 2009 15 (3) 840-850; DOI:10.1158/1078-0432.CCR-08-1918

  • Cancer Therapy: Preclinical
    In vivo Model of Follicular Lymphoma Resistant to Rituximab
    Stéphane Dalle, Sophie Dupire, Stéphanie Brunet-Manquat, Lina Reslan, Adriana Plesa and Charles Dumontet
    Clin Cancer Res February 1 2009 15 (3) 851-857; DOI:10.1158/1078-0432.CCR-08-1685

  • Cancer Therapy: Preclinical
    Antitumor Alkyl Ether Lipid Edelfosine: Tissue Distribution and Pharmacokinetic Behavior in Healthy and Tumor-Bearing Immunosuppressed Mice
    Ander Estella-Hermoso de Mendoza, Miguel A. Campanero, Janis de la Iglesia-Vicente, Consuelo Gajate, Faustino Mollinedo and María J. Blanco-Prieto
    Clin Cancer Res February 1 2009 15 (3) 858-864; DOI:10.1158/1078-0432.CCR-08-1654

  • Cancer Therapy: Preclinical
    Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates
    Yong Li, Emma Song, Syed M. Abbas Rizvi, Carl A. Power, Julia Beretov, Chand Raja, Paul J. Cozzi, Alfred Morgenstern, Christos Apostolidis, Barry J. Allen and Pamela J. Russell
    Clin Cancer Res February 1 2009 15 (3) 865-875; DOI:10.1158/1078-0432.CCR-08-1203

  • Cancer Therapy: Preclinical
    Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres
    Wei Lu, Chiyi Xiong, Guodong Zhang, Qian Huang, Rui Zhang, Jin Z. Zhang and Chun Li
    Clin Cancer Res February 1 2009 15 (3) 876-886; DOI:10.1158/1078-0432.CCR-08-1480

  • Cancer Therapy: Preclinical
    Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
    Katsuyoshi Miyashita, Kazuyuki Kawakami, Mitsutoshi Nakada, Wei Mai, Abbas Shakoori, Hironori Fujisawa, Yutaka Hayashi, Jun-ichiro Hamada and Toshinari Minamoto
    Clin Cancer Res February 1 2009 15 (3) 887-897; DOI:10.1158/1078-0432.CCR-08-0760

  • Cancer Therapy: Preclinical
    In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-α-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer
    Jing Ni, Tiejun Mai, See-Tong Pang, Imranul Haque, Kaohsing Huang, Matthew A. DiMaggio, Shaozhen Xie, Nadine S. James, Dhanalakshmi Kasi, Sherry R. Chemler and Shuyuan Yeh
    Clin Cancer Res February 1 2009 15 (3) 898-906; DOI:10.1158/1078-0432.CCR-08-1087

  • Cancer Therapy: Preclinical
    Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non–small cell Lung Cancer Cell Lines with MET Amplification
    Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka, Junji Uchida, Erina Hatashita, Yuki Yamada, Takeshi Yoshida, Kazuto Nishio, Masahiro Fukuoka, Pasi A. Jänne and Kazuhiko Nakagawa
    Clin Cancer Res February 1 2009 15 (3) 907-913; DOI:10.1158/1078-0432.CCR-08-2251

  • Cancer Therapy: Preclinical
    Ionizing Radiation Up-regulates Telomerase Activity in Cancer Cell Lines by Post-translational Mechanism via Ras/Phosphatidylinositol 3-Kinase/Akt Pathway
    Ron Ram, Orit Uziel, Orit Eldan, Eyal Fenig, Einat Beery, Shelly Lichtenberg, Yardena Nordenberg and Meir Lahav
    Clin Cancer Res February 1 2009 15 (3) 914-923; DOI:10.1158/1078-0432.CCR-08-0792

  • Cancer Therapy: Preclinical
    A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
    Matthew M. Seavey, Zhen-Kun Pan, Paulo C. Maciag, Anu Wallecha, Sandra Rivera, Yvonne Paterson and Vafa Shahabi
    Clin Cancer Res February 1 2009 15 (3) 924-932; DOI:10.1158/1078-0432.CCR-08-2283

  • Cancer Therapy: Preclinical
    MDM2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma
    Yoko Tabe, Denise Sebasigari, Linhua Jin, Martina Rudelius, Theresa Davies-Hill, Kazunori Miyake, Takashi Miida, Stefania Pittaluga and Mark Raffeld
    Clin Cancer Res February 1 2009 15 (3) 933-942; DOI:10.1158/1078-0432.CCR-08-0399

  • Cancer Therapy: Preclinical
    Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
    Hao Wang, Huafeng Wei, Ruiping Zhang, Sheng Hou, Bohua Li, Weizhu Qian, Dapeng Zhang, Gen Kou, Jianxin Dai and Yajun Guo
    Clin Cancer Res February 1 2009 15 (3) 943-950; DOI:10.1158/1078-0432.CCR-08-2381

  • Cancer Therapy: Preclinical
    Human-Like Mouse Models for Testing the Efficacy and Safety of Anti-β2-Microglobulin Monoclonal Antibodies to Treat Myeloma
    Jing Yang, Yabing Cao, Sungyongl Hong, Haiyan Li, Jianfei Qian, Larry W. Kwak and Qing Yi
    Clin Cancer Res February 1 2009 15 (3) 951-959; DOI:10.1158/1078-0432.CCR-08-1823

  • Cancer Therapy: Preclinical
    B7 Blockade Alters the Balance between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer
    Penghui Zhou, Xincheng Zheng, Huiming Zhang, Yang Liu and Pan Zheng
    Clin Cancer Res February 1 2009 15 (3) 960-970; DOI:10.1158/1078-0432.CCR-08-1611

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
    Qiang Gao, Xiao-Ying Wang, Shuang-Jian Qiu, Ichiro Yamato, Masayuki Sho, Yoshiyuki Nakajima, Jian Zhou, Bai-Zhou Li, Ying-Hong Shi, Yong-Sheng Xiao, Yang Xu and Jia Fan
    Clin Cancer Res February 1 2009 15 (3) 971-979; DOI:10.1158/1078-0432.CCR-08-1608

  • Imaging, Diagnosis, Prognosis
    Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis
    T.W. Geurts, M.L.F van Velthuysen, F. Broekman, T. Hooft van Huysduynen, M.W.M. van den Brekel, N. van Zandwijk, H. van Tinteren, P. Nederlof, A.J.M. Balm and R.H. Brakenhoff
    Clin Cancer Res February 1 2009 15 (3) 980-985; DOI:10.1158/1078-0432.CCR-08-1968

  • Imaging, Diagnosis, Prognosis
    Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck
    Sungheon Kim, Laurie Loevner, Harry Quon, Eric Sherman, Gregory Weinstein, Alex Kilger and Harish Poptani
    Clin Cancer Res February 1 2009 15 (3) 986-994; DOI:10.1158/1078-0432.CCR-08-1287

  • Imaging, Diagnosis, Prognosis
    The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
    Davide Rossi, Michaela Cerri, Clara Deambrogi, Elisa Sozzi, Stefania Cresta, Silvia Rasi, Lorenzo De Paoli, Valeria Spina, Valter Gattei, Daniela Capello, Francesco Forconi, Francesco Lauria and Gianluca Gaidano
    Clin Cancer Res February 1 2009 15 (3) 995-1004; DOI:10.1158/1078-0432.CCR-08-1630

  • Imaging, Diagnosis, Prognosis
    Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
    Sze Chuen Cesar Wong, Charles Ming Lok Chan, Brigette Buig Yue Ma, Edwin Pun Hui, Simon Siu Man Ng, Paul Bo San Lai, Moon Tong Cheung, Elena Siu Fong Lo, Amanda Kit Ching Chan, Money Yan Yee Lam, Thomas Chi Chuen Au and Anthony Tak Cheung Chan
    Clin Cancer Res February 1 2009 15 (3) 1005-1012; DOI:10.1158/1078-0432.CCR-08-1515

  • Imaging, Diagnosis, Prognosis
    A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma
    Laurent Zini, Vincent Cloutier, Hendrik Isbarn, Paul Perrotte, Umberto Capitanio, Claudio Jeldres, Shahrokh F. Shariat, Fred Saad, Philippe Arjane, Alain Duclos, Jean-Baptiste Lattouf, Francesco Montorsi and Pierre I. Karakiewicz
    Clin Cancer Res February 1 2009 15 (3) 1013-1018; DOI:10.1158/1078-0432.CCR-08-1888

  • Imaging, Diagnosis, Prognosis
    Genetic Variants in TAP Are Associated with High-Grade Cervical Neoplasia
    Mark H. Einstein, Suzanne Leanza, Lydia G. Chiu, Nicolas F. Schlecht, Gary L. Goldberg, Bettie M. Steinberg and Robert D. Burk
    Clin Cancer Res February 1 2009 15 (3) 1019-1023; DOI:10.1158/1078-0432.CCR-08-1207

  • Imaging, Diagnosis, Prognosis
    Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression
    Adam S. Feldman, Jacqueline Banyard, Chin-Lee Wu, W. Scott McDougal and Bruce R. Zetter
    Clin Cancer Res February 1 2009 15 (3) 1024-1031; DOI:10.1158/1078-0432.CCR-08-1143

  • Imaging, Diagnosis, Prognosis
    Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
    Heidi Schwarzenbach, Catherine Alix-Panabières, Imke Müller, Nicolas Letang, Jean-Pierre Vendrell, Xavier Rebillard and Klaus Pantel
    Clin Cancer Res February 1 2009 15 (3) 1032-1038; DOI:10.1158/1078-0432.CCR-08-1910

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Paolo Ceppi, Silvia Novello, Alberto Cambieri, Marina Longo, Valentina Monica, Marco Lo Iacono, Matteo Giaj-Levra, Silvia Saviozzi, Marco Volante, Mauro Papotti and Giorgio Scagliotti
    Clin Cancer Res February 1 2009 15 (3) 1039-1045; DOI:10.1158/1078-0432.CCR-08-1227

  • Cancer Therapy: Clinical
    Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
    Daniele Generali, Gaynor Bates, Alfredo Berruti, Maria P. Brizzi, Leticia Campo, Simone Bonardi, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Luigi Dogliotti, Alison H. Banham, Adrian L. Harris, Alberto Bottini and Stephen B. Fox
    Clin Cancer Res February 1 2009 15 (3) 1046-1051; DOI:10.1158/1078-0432.CCR-08-1507

  • Cancer Therapy: Clinical
    Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
    Hanne Krogh Jensen, Frede Donskov, Marianne Nordsmark, Niels Marcussen and Hans von der Maase
    Clin Cancer Res February 1 2009 15 (3) 1052-1058; DOI:10.1158/1078-0432.CCR-08-1296

  • Cancer Therapy: Clinical
    Treatment of Philadelphia-Positive Chronic Myeloid Leukemia with Imatinib: Importance of a Stable Molecular Response
    Francesca Palandri, Ilaria Iacobucci, Simona Soverini, Fausto Castagnetti, Angela Poerio, Nicoletta Testoni, Giuliana Alimena, Massimo Breccia, Giovanna Rege-Cambrin, Mario Tiribelli, Riccardo Varaldo, Elisabetta Abruzzese, Bruno Martino, Luigiana Luciano, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Michele Baccarani and Gianantonio Rosti
    Clin Cancer Res February 1 2009 15 (3) 1059-1063; DOI:10.1158/1078-0432.CCR-08-1195

  • Cancer Therapy: Clinical
    Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
    Jennifer A. Quinn, Sara Xiaoyin Jiang, James Carter, David A. Reardon, Annick Desjardins, James J. Vredenburgh, Jeremy N. Rich, Sridharan Gururangan, Allan H. Friedman, Darell D. Bigner, John H. Sampson, Roger E. McLendon, James E. Herndon II, Stevie Threatt and Henry S. Friedman
    Clin Cancer Res February 1 2009 15 (3) 1064-1068; DOI:10.1158/1078-0432.CCR-08-2130

  • Cancer Therapy: Clinical
    A Phase I Study of Samarium Lexidronam/Bortezomib Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma
    James R. Berenson, Ori Yellin, Ravi Patel, Herb Duvivier, Youram Nassir, Russell Mapes, Christina DiLauro Abaya and Regina A. Swift
    Clin Cancer Res February 1 2009 15 (3) 1069-1075; DOI:10.1158/1078-0432.CCR-08-1261

  • Cancer Therapy: Clinical
    Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib
    Lucia Jilaveanu, Christopher Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm, Keith T. Flaherty and Harriet M. Kluger
    Clin Cancer Res February 1 2009 15 (3) 1076-1085; DOI:10.1158/1078-0432.CCR-08-2280

  • Cancer Therapy: Clinical
    Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
    Frank M. Speetjens, Peter J.K. Kuppen, Marij J.P. Welters, Farah Essahsah, Anne Marie E.G. Voet van den Brink, M. Graziella Kallenberg Lantrua, A. Rob P.M. Valentijn, Jaap Oostendorp, Lorraine M. Fathers, Hans W. Nijman, Jan W. Drijfhout, Cornelis J.H. van de Velde, Cornelis J.M. Melief and Sjoerd H. van der Burg
    Clin Cancer Res February 1 2009 15 (3) 1086-1095; DOI:10.1158/1078-0432.CCR-08-2227

  • Cancer Therapy: Clinical
    Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
    Silvia Stacchiotti, Elena Tamborini, Andrea Marrari, Silvia Brich, Sara Arisi Rota, Marta Orsenigo, Flavio Crippa, Carlo Morosi, Alessandro Gronchi, Marco A. Pierotti, Paolo G. Casali and Silvana Pilotti
    Clin Cancer Res February 1 2009 15 (3) 1096-1104; DOI:10.1158/1078-0432.CCR-08-2050

Cancer Prevention and Susceptibility

  • Cancer Prevention and Susceptibility
    Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen
    S. Lilly Zheng, Jielin Sun, Fredrik Wiklund, Zhengrong Gao, Pär Stattin, Lina D. Purcell, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Jan Adolfsson, Jan-Erik Johansson, Aubrey R. Turner, Tamara S. Adams, Wennuan Liu, David Duggan, John D. Carpten, Bao-Li Chang, William B. Isaacs, Jianfeng Xu and Henrik Grönberg
    Clin Cancer Res February 1 2009 15 (3) 1105-1111; DOI:10.1158/1078-0432.CCR-08-1743

  • Cancer Prevention and Susceptibility
    Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
    Ilir Agalliu, Robert Gern, Suzanne Leanza and Robert D. Burk
    Clin Cancer Res February 1 2009 15 (3) 1112-1120; DOI:10.1158/1078-0432.CCR-08-1822

Letters to the Editor

  • Letters to the Editor
    Ethical Responsibility of Phase 0 Trials
    Roberto Jun Arai, Paulo Marcelo Gehm Hoff, Gilberto de Castro Jr. and Arnold Stern
    Clin Cancer Res February 1 2009 15 (3) 1121-1121; DOI:10.1158/1078-0432.CCR-08-1824

  • Letters to the Editor
    Reply to the Letter to the Editor from Arai et al.
    Emily Abdoler and David Wendler
    Clin Cancer Res February 1 2009 15 (3) 1121-1121; DOI:10.1158/1078-0432.CCR-08-2394

Back to top
PreviousNext
Clinical Cancer Research: 15 (3)
February 2009
Volume 15, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
  • Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
  • Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
  • Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases

Jump to

  • CCR Translations
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Prevention and Susceptibility
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement